Restricted accessLetterFirst published online 2023-10
Response to Letter to the Editor Entitled “Short and Long-Term Prognostic Significance of Galectin-3 in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention”
LiuHLiuY. Letter: galectin-3: an important but insufficiently explored biomarker in cardiovascular disease. Angiology. 2023;74:897-898.
2.
KöktürkUPüşüroğluHSomuncuMU, et al.Short and long-term prognostic significance of galectin-3 in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology. 2023;74:889-896.
3.
Di TanoGCarettaGDe MariaR, et al.Galectin-3 and outcomes after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention. Biomark Med. 2018;12: 21-26.
